CIK 0001745999
- Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Open-market sale CEO sold 25,000 shares at an average $107.87 ($2,696,826)
- 4 Open-market sale CFO sold 30,000 shares at an average $122.00 ($3,660,000)
- 4 Other disposition Director disposed of 400,000 shares (other)
- 4 Other disposition 10% owner disposed of 400,000 shares (other)
- 4 Open-market sale Director sold 12,045 shares at an average $106.34 ($1,280,897)
- 4 Open-market sale President & CSO sold 78,580 shares at an average $107.35 ($8,435,365)
- 4 Other acquisition Chief Executive Officer acquired 32 shares (other)
- 4 Open-market sale CFO sold 45,000 shares at an average $107.69 ($4,846,016)
- 4 Other disposition 10% owner disposed of 800,000 shares (other)
- 4 Other disposition Director disposed of 800,000 shares (other)
- 4 Insider Changes in Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 25,000 shares at an average $70.49 ($1,762,216)
- 4 Other acquisition Chief Executive Officer acquired 97 shares (code L)
- 4 Grant or award CEO acquired 69,375 shares (grant or award)
Page 10 of 12 · 238 filings